Patterns of steroid and steroid sparing regimens among older inflammatory bowel disease (IBD) patients with contraindications to tumor necrosis factor antagonists (ANTI-TNFS)

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Inflammatory Bowel ◽

Necrosis Factor ◽

Steroid Sparing

Faculty Opinions recommendation of Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732092122.793568144 ◽

2019 ◽

Author(s):

Ashish Patel

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Inflammatory Bowel ◽

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

JAMA ◽

10.1001/jama.2017.16071 ◽

2017 ◽

Vol 318 (17) ◽

pp. 1679 ◽

Cited By ~ 176

Author(s):

Magali Lemaitre ◽

Julien Kirchgesner ◽

Annie Rudnichi ◽

Fabrice Carrat ◽

Mahmoud Zureik ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Inflammatory Bowel ◽

Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease

10.1016/j.cgh.2012.06.032 ◽

2012 ◽

Vol 10 (10) ◽

pp. 1079-1087 ◽

Cited By ~ 142

Author(s):

Ingrid Ordás ◽

Brian G. Feagan ◽

William J. Sandborn

Keyword(s):

Tumor Necrosis Factor ◽

Therapeutic Drug Monitoring ◽

Bowel Disease ◽

Drug Monitoring ◽

Tumor Necrosis ◽

Therapeutic Drug ◽

Inflammatory Bowel ◽

Exam 1: Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease

10.1016/j.cgh.2021.11.025 ◽

2022 ◽

Vol 20 (2) ◽

pp. e337-e338

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Serious Infections ◽

Inflammatory Bowel ◽

Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease

10.1016/j.cgh.2016.06.025 ◽

2017 ◽

Vol 15 (1) ◽

pp. 25-36.e27 ◽

Cited By ~ 57

Author(s):

Laurent Peyrin-Biroulet ◽

Gert Van Assche ◽

David Gómez-Ulloa ◽

Laura García-Álvarez ◽

Núria Lara ◽

...

Keyword(s):

Systematic Review ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Extraintestinal Manifestations ◽

Inflammatory Bowel ◽

Risk of serious infections with vedolizumab versus tumor necrosis factor antagonists in patients with inflammatory bowel disease

10.1016/j.cgh.2020.12.030 ◽

2020 ◽

Author(s):

Julien Kirchgesner ◽

Rishi J. Desai ◽

Laurent Beaugerie ◽

Sebastian Schneeweiss ◽

Seoyoung C. Kim

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Serious Infections ◽

Inflammatory Bowel ◽

Sa1872 IMMUNOGENICITY OF TUMOR NECROSIS FACTOR ANTAGONISTS AND THE EFFECT OF DOSE ESCALATION TO IMPROVE DRUG CONCENTRATIONS AND ELIMINATE ANTIBODIES IN A LARGE INFLAMMATORY BOWEL DISEASE POPULATION

Gastroenterology ◽

10.1016/s0016-5085(20)31831-x ◽

2020 ◽

Vol 158 (6) ◽

pp. S-459-S-460

Author(s):

Robert Battat ◽

Ellen J. Scherl ◽

Suresh Pola ◽

Dana J. Lukin ◽

Anand Kumar ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Dose Escalation ◽

Bowel Disease ◽

Tumor Necrosis ◽

Drug Concentrations ◽

Inflammatory Bowel ◽

Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis

10.1016/j.cgh.2017.02.005 ◽

2017 ◽

Vol 15 (9) ◽

pp. 1359-1372.e6 ◽

Cited By ~ 24

Author(s):

Yun Qiu ◽

Ren Mao ◽

Bai-li Chen ◽

Sheng-hong Zhang ◽

Jing Guo ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Combination Therapy ◽

Bowel Disease ◽

Tumor Necrosis ◽

Meta Analysis ◽

Inflammatory Bowel ◽

Trough Levels ◽

Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease

Journal of Clinical Gastroenterology ◽

10.1097/mcg.0000000000000758 ◽

2017 ◽

Vol 51 (5) ◽

pp. 394-401 ◽

Cited By ~ 9

Author(s):

Tushar Shukla ◽

Siddharth Singh ◽

Parul Tandon ◽

Jeffrey D. McCurdy

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Cytomegalovirus Reactivation ◽

Inflammatory Bowel ◽

Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis

10.1016/j.cgh.2017.01.035 ◽

2017 ◽

Vol 15 (7) ◽

pp. 1061-1070.e1 ◽

Cited By ~ 11

Author(s):

Laura E. Targownik ◽

Aruni Tennakoon ◽

Stella Leung ◽

Lisa M. Lix ◽

Harminder Singh ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Temporal Trends ◽

Population Based ◽

Inflammatory Bowel ◽

Initiation Of Therapy ◽